Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.41
0.223.06%
Last update: Oct 9, 6:02 PM
$7.35
0.162.23%
Achieve Life Sciences Inc (ACHV) Stock Price, Quote, News & History
ACHVNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Achieve Life Sciences has a consensus price target of $14.90.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $7.35 last updated October 9, 2026 at 6:02 PM EDT.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
